MedPath

EQUAGESIC TABLETS

EQUAGESIC TABLETS

Discontinued
DIN Number

02041804

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02041804
AIG Number0301068001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N02BA71 ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (3)

ACETYLSALICYLIC ACIDActive
Strength: 250 MG / TAB
Monograph: ACETYLSALICYLIC ACID
ETHOHEPTAZINE CITRATEActive
Strength: 75 MG / TAB
Monograph: ETHOHEPTAZINE CITRATE
MEPROBAMATEActive
Strength: 200 MG / TAB
Monograph: MEPROBAMATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.